BIOHAVEN PHARMACEUTICAL HOLDING CO LTD - COM (BHVNXXXX)

Historical Portfolio Holders from Q2 2017 to Q1 2024

All holders as of March 31, 2024
Q1 2024
Type / Class
Equity / COM
Shares, excl. options Q1 2024
498 K
Holdings value Q1 2024
$27.2 M
Value change Q1 2024
$0
Grand Portfolio weight change Q1 2024
0%
Number of holders
2
Number of buys Q1 2024
0
Number of sells Q1 2024
0
Average buys Q1 2024 %
0
Average sells Q1 2024 %
0
CUSIP
G11196105
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q1 498 K $27.2 M $0 $54.69 2
2023 Q4 498 K $21.3 M +$315 K $42.80 2
2023 Q3 490 K $12.8 M +$1.04 M $26.01 1
2023 Q2 450 K $10.8 M -$4.91 M $23.92 1
2023 Q1 563 K $11.1 M -$1.07 M $28.62 2
2022 Q4 593 K $13.8 M -$8.4 B $13.87 5
2022 Q3 56.6 M $8.56 B -$529 M $151.17 225
2022 Q2 58 M $8.38 B -$184 M $145.71 309
2022 Q1 63.8 M $7.56 B +$224 M $118.57 289
2021 Q4 58.6 M $8.08 B +$250 M $137.81 269
2021 Q3 58.8 M $8.17 B -$41 M $138.91 242
2021 Q2 58.3 M $5.66 B +$5.99 M $97.08 217
2021 Q1 58.8 M $4.02 B +$309 M $68.35 216
2020 Q4 55.6 M $4.76 B -$321 M $85.71 236
2020 Q3 60.1 M $3.9 B +$35.8 M $65.01 207
2020 Q2 59.3 M $4.33 B +$149 M $73.11 215
2020 Q1 55.3 M $1.88 B +$286 M $34.03 166
2019 Q4 48.8 M $2.66 B -$6.24 M $54.44 179
2019 Q3 47.1 M $1.96 B +$167 M $41.72 177
2019 Q2 45.8 M $2 B +$319 M $43.79 193
2019 Q1 38.4 M $1.98 B +$14.5 M $51.47 166
2018 Q4 37.9 M $1.4 B +$242 M $36.98 126
2018 Q3 29.4 M $1.1 B -$40.4 M $37.55 114
2018 Q2 30.4 M $1.2 B +$118 M $39.52 99
2018 Q1 27.9 M $713 M +$196 M $25.76 96
2017 Q4 20.1 M $541 M +$88 M $26.98 88
2017 Q3 15.7 M $584 M +$84.8 M $37.38 72
2017 Q2 13.5 M $333 M +$333 M $25.00 66